A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands

Clinical trial NCT01351103 · COMPLETED

Trial details

NCT number: NCT01351103
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer BRAF Mutant Colorectal Cancer Melanoma Triple Negative Breast Cancer Head and Neck Squamous Cell Cancer Cervical Squamous Cell Cancer Esophageal Squamous Cell Cancer Lung Squamous Cell Cancer

Start date: 2011-12-01
Primary completion: 2021-06-01
Enrollment: 185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.